Literature DB >> 24814925

Pseudotyping of vesicular stomatitis virus with the envelope glycoproteins of highly pathogenic avian influenza viruses.

Gert Zimmer1, Samira Locher1, Marianne Berger Rentsch1, Stefan J Halbherr1.   

Abstract

Pseudotype viruses are useful for studying the envelope proteins of harmful viruses. This work describes the pseudotyping of vesicular stomatitis virus (VSV) with the envelope glycoproteins of highly pathogenic avian influenza viruses. VSV lacking the homotypic glycoprotein (G) gene (VSVΔG) was used to express haemagglutinin (HA), neuraminidase (NA) or the combination of both. Propagation-competent pseudotype viruses were only obtained when HA and NA were expressed from the same vector genome. Pseudotype viruses containing HA from different H5 clades were neutralized specifically by immune sera directed against the corresponding clade. Fast and sensitive reading of test results was achieved by vector-mediated expression of GFP. Pseudotype viruses expressing a mutant VSV matrix protein showed restricted spread in IFN-competent cells. This pseudotype system will facilitate the detection of neutralizing antibodies against virulent influenza viruses, circumventing the need for high-level biosafety containment.
© 2014 The Authors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24814925     DOI: 10.1099/vir.0.065201-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  Biological and protective properties of immune sera directed to the influenza virus neuraminidase.

Authors:  Stefan J Halbherr; Thomas H Ludersdorfer; Meret Ricklin; Samira Locher; Marianne Berger Rentsch; Artur Summerfield; Gert Zimmer
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  A Genome-Wide CRISPR-Cas9 Screen Reveals the Requirement of Host Cell Sulfation for Schmallenberg Virus Infection.

Authors:  Thiprampai Thamamongood; Andrea Aebischer; Valentina Wagner; Max W Chang; Roland Elling; Christopher Benner; Adolfo García-Sastre; Georg Kochs; Martin Beer; Martin Schwemmle
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

3.  Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.

Authors:  Sylvia Rothenberger; Christian Widmann; Stefan Kunz; Giulia Torriani; Evgeniya Trofimenko; Jennifer Mayor; Chiara Fedeli; Hector Moreno; Sébastien Michel; Mathieu Heulot; Nadja Chevalier; Gert Zimmer; Neeta Shrestha; Philippe Plattet; Olivier Engler
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

4.  Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting.

Authors:  Jean K Millet; Tiffany Tang; Lakshmi Nathan; Javier A Jaimes; Hung-Lun Hsu; Susan Daniel; Gary R Whittaker
Journal:  J Vis Exp       Date:  2019-03-01       Impact factor: 1.355

5.  Synthetically derived bat influenza A-like viruses reveal a cell type- but not species-specific tropism.

Authors:  Étori Aguiar Moreira; Samira Locher; Larissa Kolesnikova; Hardin Bolte; Teresa Aydillo; Adolfo García-Sastre; Martin Schwemmle; Gert Zimmer
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

6.  Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.

Authors:  Lisa Walz; Sarah-Katharina Kays; Gert Zimmer; Veronika von Messling
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

7.  A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.

Authors:  Alex B Ryder; Linda Buonocore; Leatrice Vogel; Raffael Nachbagauer; Florian Krammer; John K Rose
Journal:  J Virol       Date:  2014-12-24       Impact factor: 5.103

8.  MHC class II proteins mediate cross-species entry of bat influenza viruses.

Authors:  Umut Karakus; Thiprampai Thamamongood; Martin Schwemmle; Silke Stertz; Kevin Ciminski; Wei Ran; Sira C Günther; Marie O Pohl; Davide Eletto; Csaba Jeney; Donata Hoffmann; Sven Reiche; Jan Schinköthe; Reiner Ulrich; Julius Wiener; Michael G B Hayes; Max W Chang; Annika Hunziker; Emilio Yángüez; Teresa Aydillo; Florian Krammer; Josua Oderbolz; Matthias Meier; Annette Oxenius; Anne Halenius; Gert Zimmer; Christopher Benner; Benjamin G Hale; Adolfo García-Sastre; Martin Beer
Journal:  Nature       Date:  2019-02-20       Impact factor: 49.962

9.  Lentiviral hepatitis B pseudotype entry requires sodium taurocholate co-transporting polypeptide and additional hepatocyte-specific factors.

Authors:  L W Meredith; K Hu; X Cheng; C R Howard; T F Baumert; P Balfe; K F van de Graaf; U Protzer; J A McKeating
Journal:  J Gen Virol       Date:  2015-10-16       Impact factor: 3.891

Review 10.  Pseudotype-based neutralization assays for influenza: a systematic analysis.

Authors:  George William Carnell; Francesca Ferrara; Keith Grehan; Craig Peter Thompson; Nigel James Temperton
Journal:  Front Immunol       Date:  2015-04-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.